Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
Tommaso Cassano, Silvio Calcagnini, Lorenzo Pace, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 171

Showing 1-25 of 171 citing articles:

Cannabinoids and the expanded endocannabinoid system in neurological disorders
Luigia Cristino, Tiziana Bisogno, Vincenzo Di Marzo
Nature Reviews Neurology (2019) Vol. 16, Iss. 1, pp. 9-29
Closed Access | Times Cited: 775
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Chao Gao, Jingwen Jiang, Yuyan Tan, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 391
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
Tommaso Cassano, Rosanna Villani, Lorenzo Pace, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 118
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases
Valerio Chiurchiù, Mario van der Stelt, Diego Centonze, et al.
Progress in Neurobiology (2017) Vol. 160, pp. 82-100
Open Access | Times Cited: 116
Pharmacological Targeting of Microglial Activation: New Therapeutic Approach
Caiyun Liu, Xu Wang, Chang Liu, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 114
Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review
Ruwini Cooray, Veer Bala Gupta, Cenk Suphioglu
Molecular Neurobiology (2020) Vol. 57, Iss. 11, pp. 4878-4890
Open Access | Times Cited: 111
Role of the endocannabinoid system in drug addiction
Jorge Manzanares, David Cabañero, Nagore Puente, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 108-121
Open Access | Times Cited: 103
Monoacylglycerol lipase (MAGL) as a promising therapeutic target
Ana Gil-Ordóñez, Mar Martín‐Fontecha, Silvia Ortega‐Gutiérrez, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 18-32
Closed Access | Times Cited: 102
Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
Felipe Patricio, Alan Axel Morales-Andrade, Aleidy Patricio-Martínez, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 96
Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system
Marta Aymerich, Ester Aso, Miguel Angel Abellanas, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 67-84
Open Access | Times Cited: 95
Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues
Cristina Anna Gallelli, Silvio Calcagnini, Adele Romano, et al.
Antioxidants (2018) Vol. 7, Iss. 7, pp. 93-93
Open Access | Times Cited: 89
Exogenous activation of cannabinoid-2 receptor modulates TLR4/MMP9 expression in a spinal cord ischemia reperfusion rat model
Na Jing, Bo Fang, Zhe Li, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 72
Exploring Pharmacological Mechanisms of Essential Oils on the Central Nervous System
Giselle A. Borges e Soares, Tanima Bhattacharya, Tulika Chakrabarti, et al.
Plants (2021) Vol. 11, Iss. 1, pp. 21-21
Open Access | Times Cited: 63
The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation
A. P. Young, Eileen M. Denovan‐Wright
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 54
Endocannabinoid signaling in astrocytes
Abel Eraso‐Pichot, Sandrine Pouvreau, Alexandre Oliveira-Pinto, et al.
Glia (2022) Vol. 71, Iss. 1, pp. 44-59
Open Access | Times Cited: 52
Neuroinflammation, Early-Life Adversity, and Brain Development
Susan L. Andersen
Harvard Review of Psychiatry (2022) Vol. 30, Iss. 1, pp. 24-39
Open Access | Times Cited: 40
Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
Zak M. Whiting, Jiazhen Yin, Sara M. de la Harpe, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 9, pp. 754-771
Closed Access | Times Cited: 40
Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions
Ana Tadijan, Ignacija Vlašić, Josipa Vlainić, et al.
Antioxidants (2022) Vol. 11, Iss. 10, pp. 2049-2049
Open Access | Times Cited: 38
Interplay Between n‐3 and n‐6 Long‐Chain Polyunsaturated Fatty Acids and the Endocannabinoid System in Brain Protection and Repair
Simon C. Dyall
Lipids (2017) Vol. 52, Iss. 11, pp. 885-900
Open Access | Times Cited: 71
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid
Ewa Kozela, Ana Juknat, Zvi Vogel
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 8, pp. 1669-1669
Open Access | Times Cited: 67
Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract
Giorgia Galiazzo, Fiorella Giancola, Agnese Stanzani, et al.
Histochemistry and Cell Biology (2018) Vol. 150, Iss. 2, pp. 187-205
Closed Access | Times Cited: 67
Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief
Francesca Gado, Lorenzo Di Cesare Mannelli, Elena Lucarini, et al.
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 1, pp. 276-287
Open Access | Times Cited: 62
Can We Treat Neuroinflammation in Alzheimer’s Disease?
Sandra Sánchez‐Sarasúa, Iván Fernández-Pérez, Verónica Espinosa‐Fernández, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8751-8751
Open Access | Times Cited: 54
Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates
Monika Marcinkowska, Joanna Śniecikowska, Nikola Fajkis, et al.
CNS Drugs (2020) Vol. 34, Iss. 3, pp. 243-268
Open Access | Times Cited: 51
CB2R Activation Regulates TFEB-Mediated Autophagy and Affects Lipid Metabolism and Inflammation of Astrocytes in POCD
Lieliang Zhang, Xifeng Wang, Wen Yu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top